Natural and acquired inhibitors of hemostasis in selected symptomatic outpatients with venous thromboembolic disease

Haematologica

Volumn 82, Issue 4, 1997, Pages 420-422

  Bazzan, Mario ^a,b   Tamponi, Giacomo ^a   Vaccarino, Antonella ^a   Montaruli, Barbara ^a   Aluffi, Enzo ^b   Schinco, Piercarla ^a   Pannocchia, Antonella ^a   Borchiellini, Alessandra ^a   Rabbia, Claudio ^a   Pileri, Alessandro ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b MOLINETTE HOSPITAL   (Italy)

Author keywords

APC R; Hemostasis; Thromboembolism; Thrombosis

Indexed keywords

ACTIVATED PROTEIN C; LUPUS ANTICOAGULANT;

ADULT; AGED; ARTICLE; COST EFFECTIVENESS ANALYSIS; DEEP VEIN THROMBOSIS; DYSFIBRINOGENEMIA; ENZYME ACTIVATION; FAMILY HISTORY; FEMALE; GENE MUTATION; HEMOSTASIS; HUMAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE; THROMBOEMBOLISM; VEIN THROMBOSIS;

ADULT; ANTITHROMBIN III; FEMALE; HEMOSTASIS; HUMANS; LUPUS COAGULATION INHIBITOR; MALE; MIDDLE AGED; PROTEIN C; PROTEIN S; THROMBOPHLEBITIS;

EID: 0031440309     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Girolami A, Prandoni P, Simioni P, Girolami B, Scarano L, Zanon E. Pathogenesis of venous thromboembolism. Haematologica 1995; 80(suppl to no. 2):25-35.
2. Finazzi G, Barbui T. Different incidence of venous thrombosis in patients with inherited deficiencies of antithrombin III, protein C and S. Thromb Haemost 1994; 71:15-8.
3. Milatich PJ, Prescott SM, White R, Majerus PW, Bowill EG. Inherited predisposition to thrombosis. Cell 1993; 72:477-80.
4. Pabinger I, Kyrle PA, Heistinger M, Eichinger S, Wittman E, Lechner K. The risk of thromboembolism in asymptomatic patients with protein C and protein S deficiency: a prospective cohort study. Thromb Haemost 1994; 71:441-5.
5. De Stefano V, Finazzi G, Mannucci PM. Inherited thrombophilia: pathogenesis, clinical syndromes, and management. Blood 1994; 97:3531-44.
6. Svensson PJ, Dahlbäck B. Resistance to activated protein C as a basis for venous thrombosis. N Engl J Med 1994; 330:517-22.
7. Dahlbäck B. Inherited resistance to activated protein C, a major basis of venous thrombosis, is caused by deficient anticoagulant cofactor function of factor V. Haematologica 1995; 80(suppl to no. 2):102-13.
8. Heijboer H, Brandjes DPM, Buller HR, Sturk A, ten Cate JW. Deficiencies of coagulation-inhibiting and fibrinolytic proteins in outpatients with deep-vein thrombosis. N Engl J Med 1990; 323: 1512-6.
9. Bazzan M, Aluffi E, Vaccarino A, Schinco P, Montaruli B. Resistance to activated protein C (APC-r) in selected outpatients with pulmonary embolism. Lancet 1996; 347:1842.
10. Triplett DA. Antiphospholipid antibodies, lupus anticoagulants and thromboembolic disease. Haematologica 1995; 80(suppl to no. 2): 122-6.
11. Ginsberg JS, Wells PS, Brill-Edwards P, et al. Antiphospholipid antibodies and venous thromboembolism. Blood 1995; 86:3685-91.
12. Khamashta MA, Cuadrado MJ, Mujic F, Taub NA, Unt BJ, Hughes GRV. The management of thrombosis in the antiphospholipid-antobody syndrome. N Engl J Med 1995; 332:993-7.
13. Briet E, Van Der Meer FJ, Rosendaal FR, Houwing-Dustermaat JJ, Van Houwelingen HC. The family history and inherited thrombophilia. Br J Haematol 1994; 87:348-52.
14. Tosetto A, Frezzato M, Rodeghiero F. Family history and inherited thrombophilia. Br J Haematol 1995; 89:227-8.
15. Lensing AWA, Prandoni P, Branjies D, et al. Detection of deep vein thrombosis by real-time B-mode ultrasonography. N Engl J Med 1989; 320:342-5.
16. Heijboer H, Buller HR, Lensing AWA, Turpie AGG, Colly LP, Ten Cate JW. A comparison of real-time compression ultrasonography with impedance plethysmography for the diagnosis of deep-vein thrombosis. N Engl J Med 1993; 329:1365-9.
17. Value of the ventilation/perfusion scan in acute pulmonary embolism: results of the Prospective Investigation of Pulmonary Embolism Diagnosis (PIOPED). JAMA 1990; 263:2753-9.
18. Brandt JT, Triplett DA, Alving B, Scahrrer I. Criteria for diagnosis of lupus anticoagulant: an update. On behalf of the Subcommittee on lupus anticoagulant/antiphospholipid antibody of the Scientific and Standardization Committee of the ISTH. Thromb Haemost 1995; 74:1185-90.
19. Triplett DA, Brandt JT, Kaczor D, Schaffer J. Laboratory diagnosis of lupus inhibitors: a comparison of the tissue thromboplastin inhibition procedure with a new platelet neutralization procedure. Am J Clin Pathol 1983; 79:678-82.
20. Bertina RM, Koelemann BPC, Koster T, et al. Mutation in blood coagulation factor V associated with resistance to activated protein C Nature 1994; 62:654-60.
21. Voorberg J, Roelse J, Koopmann R, et al. Association of idiopathic venous thromboembolism with single point mutation at Arg506 of factor V. Lancet 1994; 343:1535-6.
22. De Stefano V, Leone G. Resistance to activated protein C due to mutated factor V as a novel cause of inherited thrombophilia. Haematologica 1995; 80:344-56.